Platelet count

There are 360 papers on platelet count in aging research: 20 trials and 279 observational studies in people, 40 in animals, 16 reviews. The newest story, Nov 11, 2026: “Mildly low platelets alone linked to modest blood disease risk”.

Biomarker

360 papers study it52 more mention it75 findings

MeSH

44 new papers in 30 daysSee all 412 papers on platelet count

“both elevated Lp(a) (HR 1.250; 95% CI 1.118-1.325) and increased platelet count (HR 1.056; 95% CI 1.005-1.110) were independently associated with higher MACE risk.”
Lp(a), platelet count, aspirin and cardiovascular outcome: a prospective cohort analysisFrontiers in cardiovascular medicine2026doi:10.3389/fcvm.2026.1932150
  • Human trial20
  • Humans279
  • Animals40
  • In silico2

Interventions

13

Chronological age

upin mice1

1 study
  1. Chronological age increases platelet count in mice.

    “These changes were associated with increased platelet production, reflected by elevated reticulocyte levels and peripheral platelet counts”

    Animals

    Age-associated inflammation is accompanied by JAK1-STAT1 signaling activation, megakaryocyte apoptosis, and enhanced thrombopoiesis in naturally aged mice

    Experimental gerontology

More on Chronological age

TPO-RAs combined with sirolimus

upin humans1

1 study
  1. TPO-RAs combined with sirolimus is linked with higher platelet count in relapsed immune thrombocytopenia.

    “The combination of TPO-RAs and sirolimus significantly improved platelet counts and sustained response rates.”

    Humansin relapsed immune thrombocytopenian = 50

    Efficacy and safety of TPO-RA combined with sirolimus in the treatment of relapsed immune thrombocytopenia

    Hematology (Amsterdam, Netherlands)

More on TPO-RAs combined with sirolimus

Porcine liver xenotransplantation

downin humans1

1 study
  1. Porcine liver xenotransplantation decreases platelet count in humans during extracorporeal cross-circulation with transgenic porcine livers (80%-90% cleared).

    “In all 3 initial cases, 80%-90% of circulating and transfused platelets were rapidly cleared”

    Human trialduring extracorporeal cross-circulation with transgenic porcine liversn = 3

    Graft-derived VWF drives platelet activation and thrombocytopenia during porcine liver xenotransplantation to brain-dead human recipients

    The Journal of clinical investigation

More on Porcine liver xenotransplantation

Tirzepatide cessation with intravenous immunoglobulin and corticosteroids

upin humans1

1 study
  1. Tirzepatide cessation with intravenous immunoglobulin and corticosteroids are linked with higher platelet count in humans (combined treatment after tirzepatide-associated thrombocytopenia) (returned to baseline).

    “Platelet counts ultimately increased to baseline in response to the treatment with tirzepatide cessation, IVIG, and corticosteroids.”

    Humanscombined treatment after tirzepatide-associated thrombocytopeniamalesn = 1

    A Rare Case of Tirzepatide-Associated Immune Thrombocytopenia

    Cureus

More on Tirzepatide cessation with intravenous immunoglobulin and corticosteroids

Vegan diet

downin humans1

1 study
  1. Vegan diet decreases platelet count in humans (-21 (-31) *103/μL vs. -1.21 ± 28.37 *103/μL, p = 0.035).

    “Median change scores in platelets differed between VD and MD participants (- 21 (- 31) *103/μL in the VD group vs. - 1.21 ± 28.37 *103/μL in the MD group, p = 0.035)”

    Human trial8 weeksn = 57

    Impact of an eight-week isocaloric vegan dietary intervention on hemogram parameters and lymphocyte subsets: a randomized-controlled trial

    BMC medicine

More on Vegan diet

Low-inflammatory diet

upin humans1

1 study
  1. Low-inflammatory diet increases platelet count in humans.

    “Low inflammatory diets increase platelet counts and activity overall.”

    Review

    Optimizing orthobiologic therapies with exercise, diet, and supplements

    PM & R : the journal of injury, function, and rehabilitation

More on Low-inflammatory diet

Exercise

upin humans1

1 study
  1. Exercise increases platelet count in humans.

    “Exercise intensity appears to increase platelet count and increases adhesion as well as release of growth factors.”

    Review

    Optimizing orthobiologic therapies with exercise, diet, and supplements

    PM & R : the journal of injury, function, and rehabilitation

More on Exercise

Everolimus

downin humans1

1 study
  1. Everolimus decreases platelet count in younger patients (≤30 years old) (-50 vs -14).

    “Platelet counts decreased significantly more in younger patients (≤ 30 years old) compared to older patients (- 50 vs - 14, P = 0.020).”

    Human trialin younger patients (≤30 years old)

    The impact of everolimus on hematologic parameters in patients with renal angiomyolipoma associated with tuberous sclerosis complex

    Discover oncology

More on Everolimus

Atorvastatin + acetylcysteine

upin humans1

1 study
  1. Atorvastatin + acetylcysteine increases platelet count in humans (steroid-resistant or relapsed primary immune thrombocytopenia) (60% global response, 53.3% complete response).

    “All of the patients in the responder group had significant increases in their platelet counts after treatment (p < 0.05).”

    Human trialsteroid-resistant or relapsed primary immune thrombocytopeniaatorvastatin 40 mg daily, N-acetyl cysteine 400 mg every 8 hup to 12 monthsn = 15

    Evaluation of the Effects of Atorvastatin and N-Acetyl Cysteine on Platelet Counts in Patients with Primary Immune Thrombocytopenia: An Exploratory Clinical Trial

    Medicina (Kaunas, Lithuania)

More on Atorvastatin + acetylcysteine

Sitagliptin

downin humans1

1 study
  1. Sitagliptin decreases platelet count in humans (versus control without sitagliptin).

    “except for cystatin C elevation and platelet count reduction in sitagliptin group”

    Human trialversus control without sitagliptin12 months

    Efficacy and safety of sitagliptin treatment in older adults with moderately controlled type 2 diabetes: the STREAM study

    Scientific reports

More on Sitagliptin

Navitoclax

downin humans1

1 study
  1. Navitoclax decreases platelet count in humans.

    “There was a significant reduction following a single dose of navitoclax, which was observed to begin as soon as one hour after dosing (data not shown).”

    Human trialn = 55

    Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity

    The Lancet. Oncology

More on Navitoclax

All 13

Effects

3

Lumbar bone mineral density

mediatesin humans1

1 study
  1. Platelet count is linked with lumbar bone mineral density in humans (mediation of the ApoB-100 association) (20.60% suppressive indirect association).

    “while platelet count showed a suppressive indirect association (20.60%)”

    Humansmediation of the ApoB-100 associationfemalesn = 1,429

    Relationship between serum ApoB-100 and lumbar bone mineral density in postmenopausal women: a retrospective analysis of a health screening population

    Frontiers in endocrinology

Bone mineral density

no changein humans1

1 study
  1. Platelet count was not clearly linked with bone mineral density in humans.

    “we found no clear association between platelet count and BMD in the female group”

    Humansfemales

    A Novel Mechanism for Bone Loss: Platelet Count Negatively Correlates with Bone Mineral Density via Megakaryocyte-Derived RANKL

    International journal of molecular sciences

More on Bone mineral density

Disability or all-cause mortality

no changein humans1OR 1.7

1 study
  1. Platelet count was not clearly linked with disability or all-cause mortality in participants with low grip strength, lowest vs highest quartile (OR 1.70, 95% CI 0.88-3.15).

    “but not in those with low grip strength (multivariable OR, 1.70; 95% CI, 0.88-3.15; ptrend = 0.135)”

    Humansin participants with low grip strength, lowest vs highest quartile

    Grip strength affects the association between platelet count and disability-free survival: Evidence from the China Health and Retirement Longitudinal Study

    Archives of gerontology and geriatrics

Upstream

4

Age

downin humans3downin reviews1

4 studies
  1. Age is linked with lower platelet count in humans.

    “largely driven by an age-associated decline in platelet counts.”

    Humans

    Determinants of Age-Related Increase in the Fibrosis-4 Index in Primary Care: Implications for Advanced Fibrosis Screening in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease

    Kanzo

  2. age is linked with lower platelet count in humans (severe isolated traumatic brain injury) (219,000 ± 93,000 vs. 242,000 ± 76,000/μL, p < .001).

    “Patients aged >50 had lower admission platelet counts (219,000 ± 93,000 vs. 242,000 ± 76,000/μL; p < .001)”

    Humanssevere isolated traumatic brain injuryn = 1,298

    Age, admission platelet count, and mortality in severe isolated traumatic brain injury: A retrospective cohort study

    Transfusion

  3. Age is linked with lower platelet count in humans (older adults (65-88 years) compared with young adults (20-30 years)).

    “Platelet count decreased and mean platelet volume, aggregation, and P-selectin expression increased during aging compared with young adults was found.”

    Humansolder adults (65-88 years) compared with young adults (20-30 years)

    Increased platelet function during frailty

    Experimental hematology

  4. Age decreases platelet count (aging).

    “Aging reprograms the platelet compartment at multiple levels, including reduced counts”

    Reviewaging

    The evolving role of platelets in aging and cancer progression

    Frontiers in cell and developmental biology

Chronological age

downin humans1

1 study
  1. Chronological age is linked with lower platelet count in injured patients.

    “platelet count and functional profiles demonstrated independent associations with increasing age at all time points measured - reduced platelet count”

    Humansin injured patients

    Aging at the Cellular Level: An Exploratory Analysis of the Effect of Age on Platelet Dynamics in Injured Patients

    Shock (Augusta, Ga.)

Alzheimer's disease

downin humans1

1 study
  1. Alzheimer's disease is linked with lower platelet count in humans.

    “Compared to Aβ-neg controls, Aβ-pos patients showed lower platelet count and higher MPV.”

    Humans

    Relationships between diabetes-related vascular risk factors and neurodegeneration biomarkers in healthy aging and Alzheimer's disease

    Neurobiology of aging

More on Alzheimer's disease

Heterocephalus glaber

downin naked mole-rats1

1 study
  1. Heterocephalus glaber decreases platelet count in naked mole-rats (compared with short-lived mice).

    “Platelet numbers are lower compared to short-lived mice”

    Animalscompared with short-lived mice

    The hematopoietic landscape at single-cell resolution reveals unexpected stem cell features in naked mole-rats

    bioRxiv (Cold Spring Harbor Laboratory)Preprint

More on Heterocephalus glaber

Associations

42

Mortality

downin humans3upin humans1HR 0.85–0.91

4 studies
  1. Platelet count is associated with mortality in humans (proximal humerus fractures; multivariable Cox regression) (HR 0.91, 95% CI 0.86–0.96).

    “platelet count (HR: 0.91, 95% CI: 0.86–0.96; p=0.001) were associated with lower mortality risk.”

    Humansproximal humerus fractures; multivariable Cox regressionn = 261

    Mortality Following Proximal Humerus Fractures in Elderly Patients: A Retrospective Cohort Study of Clinical and Laboratory Predictors

    Geriatric orthopaedic surgery & rehabilitation

  2. Platelet count is associated with mortality in humans (AECOPD).

    “both low and high platelet counts in patients with AECOPD were found to be significantly associated with an increased risk of all-cause mortality”

    HumansAECOPD48 (33-58) months58.7% malesn = 853

    Platelet count has a U-shaped association with all-cause mortality in COPD patients

    Scientific reports

  3. Platelet count is associated with mortality in humans (Cardio-renal-metabolic multimorbidity; platelet count 228-356×103cells/μL) (15% lower risk; HR 0.85, 95% CI 0.74-0.98).

    “15% (HR, 0.85 [95% CI, 0.74-0.98]; P=0.023)”

    HumansCardio-renal-metabolic multimorbidity; platelet count 228-356×103cells/μLMedian follow-up of 71 monthsn = 4,482

    Associations Between Hematologic Parameters and All-Cause Death in Individuals With Cardio-Renal-Metabolic Multimorbidity: A National Cohort Study

    Journal of the American Heart Association

  4. Platelet count is associated with mortality in humans (severe isolated traumatic brain injury) (OR 0.998, p < .001-.041).

    “decreasing admission platelet counts (OR0.998) were independently associated with mortality (p < .001-.041).”

    Humanssevere isolated traumatic brain injuryn = 1,298

    Age, admission platelet count, and mortality in severe isolated traumatic brain injury: A retrospective cohort study

    Transfusion

Hypertension

upin humans2downin humans1HR 1.07

3 studies
  1. Platelet count is linked with a higher risk of hypertension in humans (HR = 1.07; 95% CI = 1.05-1.09).

    “Higher PLT (HR = 1.07; 95% confidence interval (CI) = 1.05-1.09) and PDW (HR = 1.03; 95% CI = 1.01-1.04) were associated with greater hypertension risk”

    Humansmedian follow-up of 8.2 yearsn = 51,191

    Platelet indices and incident hypertension: effect modification by body mass index in a Chinese cohort

    Journal of global health

  2. Platelet count predicts hypertension in humans within 5 years postpartum in preeclampsia patients.

    “the generalized estimating equation highlighted uric acid (UA), platelet (PLT), and alanine aminotransferase (ALT) as key predictors”

    Humanswithin 5 years postpartum in preeclampsia patients5 yearsfemalesn = 280

    Predicting hypertension in preeclampsia patients within five years postpartum: analysis of influencing factors and nomogram development

    Archives of medical science : AMS

  3. Platelet count is associated with hypertension in humans (participants with low circulating CD34-positive cell count (<1.01 cells/μL)) (multivariable-OR = 1.47 (1.12, 1.91)).

    “Platelet count is positively associated with hypertension among participants with a low CD34-positive cell count (multivariable-OR (odds ratio) for hypertension of 1 standard deviation (SD) increments in platelets (5.24 × 104/μL) = 1.47 (1.12, 1.91))”

    Humansparticipants with low circulating CD34-positive cell count (<1.01 cells/μL)malesn = 580

    Platelets and circulating CD34-positive cells as an indicator of the activity of the vicious cycle between hypertension and endothelial dysfunction in elderly Japanese men

    Atherosclerosis

More on Hypertension

Sarcopenia

upin humans2OR 1.009–1.82

2 studies
  1. Platelet count predicts sarcopenia in male patients with liver cirrhosis (OR 1.009, 95% CI 1.003-1.015, P=0.004).

    “platelet count (OR=1.009, 95%CI: 1.003-1.015, P=0.004) were predictors of sarcopenia in male patients with liver cirrhosis”

    Humansin male patients with liver cirrhosismalesn = 195

    Development and validation of a prediction model for sarcopenia in male patients with liver cirrhosis

    Zhonghua yi xue za zhi

  2. Platelet count is associated with sarcopenia in humans (OR 1.82, 95% CI 1.20–2.78).

    “This association remained significant in the fully adjusted model [OR (95%CI) =1.82 (1.20 to 2.78), p-value =0.005 for PLT; OR (95%CI) =1.57 (1.03 to 2.40), p-value =0.035 for PWR].”

    Humans

    Association between platelet, white blood cell count, platelet to white blood cell ratio and sarcopenia in community-dwelling older adults: focus on Bushehr Elderly Health (BEH) program

    BMC geriatrics

More on Sarcopenia

Bone mineral density

downin humans2

2 studies
  1. Platelet count is associated with bone mineral density in humans (postmenopausal women with osteoporosis) (0.773 vs. 0.83 gr/cm2, p = 0.03).

    “lower lumbar spine BMD (0.773 vs. 0.83 gr/cm2, p = 0.03)”

    Humanspostmenopausal women with osteoporosislumbar spinefemalesn = 124

    Exploring the Association Between Platelet Count, the Systemic Immune Inflammation Index, and Fracture Risk in Postmenopausal Women with Osteoporosis: A Cross-Sectional Study

    Journal of clinical medicine

  2. Platelet count is associated with bone mineral density in humans.

    “a significant negative correlation was found between platelet count and BMD in the male group.”

    Humansmales

    A Novel Mechanism for Bone Loss: Platelet Count Negatively Correlates with Bone Mineral Density via Megakaryocyte-Derived RANKL

    International journal of molecular sciences

More on Bone mineral density

Frailty

downin humans1upin humans1HR 0.998

2 studies
  1. Platelet count is linked with a lower risk of frailty in elderly patients with OSAS (HR = 0.998, 95% CI: 0.996-1.000, P = 0.040).

    “platelet count(PLTC)(HR = 0.998, 95% CI: 0.996-1.000, P = 0.040), the mean arterial oxygen saturation(MSaO2)(HR = 0.950, 95% CI: 0.918–0.984, P = 0.005) are protect factors”

    Humansin elderly patients with OSAS

    Association analysis of frailty with obstructive sleep apnea syndrome in elderly patients – A Multicenter Cohort Study

    Research SquarePreprint

  2. Frailty is associated with platelet count in humans.

    “Among the components of the full blood count, platelet numbers were positively associated with frailty index.”

    Humansn = 184

    Relationships Between Age, Frailty, Length of Care Home Residence and Biomarkers of Immunity and Inflammation in Older Care Home Residents in the United Kingdom

    Frontiers in aging

Carotid intima-media thickness

upin humans1no changein humans1

2 studies
  1. Platelet count is associated with carotid intima-media thickness in humans (hypertensive participants with a low CD34-positive cell count) (β = 0.26, p = 0.008).

    “platelet count is positively associated with carotid intima-media thickness related to endothelial dysfunction among hypertensive participants with a low CD34-positive cell count (standardized parameter estimate (β) = 0.26, p = 0.008)”

    Humanshypertensive participants with a low CD34-positive cell countmales

    Platelets and circulating CD34-positive cells as an indicator of the activity of the vicious cycle between hypertension and endothelial dysfunction in elderly Japanese men

    Atherosclerosis

  2. Platelet count is associated with carotid intima-media thickness in humans (Non-hypertensive subjects; adjusted for classical cardiovascular risk factors) (β = -0.05, p = 0.356).

    “platelet count did not significantly correlate with carotid intima media thickness (β = -0.05, p = 0.356)”

    HumansNon-hypertensive subjects; adjusted for classical cardiovascular risk factorsmales

    Platelets as an indicator of vascular repair in elderly Japanese men

    Oncotarget

More on Carotid intima-media thickness

24-month all-cause mortality

downin humans1HR 0.9966

1 study
  1. Platelet count is associated with 24-month all-cause mortality in humans (Adjusted HR 0.9966, 95% CI 0.9939–0.9994).

    “lower platelet count (adjusted HR 0.9966, 95% CI 0.9939–0.9994; p = 0.017), and lower albumin”

    HumansAfter major lower extremity amputation for diabetic foot complications; lower platelet count associated with higher mortality24 monthsn = 72

    Development of an exploratory preoperative laboratory-based score for 24-month mortality after major lower extremity amputation in geriatric diabetic foot patients

    BMC geriatrics

Incident stroke

upin humans1HR 1.16

1 study
  1. Platelet count is associated with incident stroke in humans (Hypertension and stroke-free at baseline) (HR 1.16 per 1-SD increase, 95% CI 1.07–1.25).

    “Platelet count was positively associated with stroke (hazard ratio per 1-SD increase, 1.16; 95% confidence interval, 1.07-1.25)”

    HumansHypertension and stroke-free at baseline2011–2020n = 3,963

    Association between platelet-to-high-density lipoprotein cholesterol ratio and incident stroke among adults with hypertension: A longitudinal CHARLS cohort study

    The Journal of international medical research

More on Incident stroke

Motoric cognitive risk syndrome

upin humans1OR 1.17

1 study
  1. Platelet count is associated with motoric cognitive risk syndrome in humans after adjustment for potential confounders (OR 1.17, 95% CI 1.04 to 1.32).

    “higher PLT (OR=1.17, 95% CI 1.04 to 1.32, p=0.007) and PCT (OR=1.13, 95% CI 1.01 to 1.26, p=0.046) were associated with greater odds of MCR.”

    Humansafter adjustment for potential confoundersn = 4,080

    Association between peripheral platelet markers and motoric cognitive risk syndrome: a cross-sectional analysis of data from the WCHAT study

    BMJ open

More on Motoric cognitive risk syndrome

Major adverse cardiovascular events

upin humans1HR 1.056

1 study
  1. Platelet count is associated with major adverse cardiovascular events in humans (HR 1.056; 95% CI 1.005-1.110).

    “both elevated Lp(a) (HR 1.250; 95% CI 1.118-1.325) and increased platelet count (HR 1.056; 95% CI 1.005-1.110) were independently associated with higher MACE risk.”

    HumansFree of prior cardiovascular disease; increased platelet count in upper tertile, >273 × 109/LMedian follow-up of 13.4 yearsn = 250,927

    Lp(a), platelet count, aspirin and cardiovascular outcome: a prospective cohort analysis

    Frontiers in cardiovascular medicine

More on Major adverse cardiovascular events

All 42

Latest

Dec 2025: 12Jan 2026: 16Feb 2026: 11Mar 2026: 17Apr 2026: 7May 2026: 5Jun 2026: 7Jul 2026: 7Aug 2026: 9Sep 2026: 14Oct 2026: 37Nov 2026: 17159 papers in 12 months
BMJ Medicine

Mildly low platelets alone linked to modest blood disease risk

Ten-year blood disease risks were at most 4% in UK adults and 7% in Denmark, versus at most 2% with normal platelet and hemoglobin levels.Ten-year blood disease risks were at most 4% in UK adults and 7% in Denmark, versus at most 2% with normal platelet and hemoglobin levels.

Cohort · 485,103 peopleHematologic disease
CNS Neuroscience & Therapeutics

Chronic pain and blood chemistry linked to brain disorders

A prospective cohort study of 174,630 UK Biobank participants linked a pain-related blood pattern to depression, anxiety and stroke over a median 15.6 years.A prospective cohort study of 174,630 UK Biobank participants linked a pain-related blood pattern to depression, anxiety and stroke over a median 15.6 years.

Cohort · 174,630 peopleMechanisms
Blood Advances

Monitoring detected blood cancers with less marrow scarring

The median share of JAK2 gene copies carrying a mutation was 13.0% at diagnosis in monitored cases versus 41.3% in referral-diagnosed cases.The median share of JAK2 gene copies carrying a mutation was 13.0% at diagnosis in monitored cases versus 41.3% in referral-diagnosed cases.

Cohort · 61 peopleInterventions

See all 412 papers on platelet count